• Publications
  • Influence
Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.
BACKGROUND Thyroid nodules are a common clinical problem, and differentiated thyroid cancer is becoming increasingly prevalent. Since the publication of the American Thyroid Association's guidelinesExpand
  • 6,783
  • 289
  • PDF
Management guidelines for patients with thyroid nodules and differentiated thyroid cancer.
  • 1,981
  • 95
  • PDF
Preoperative diagnosis of benign thyroid nodules with indeterminate cytology.
BACKGROUND Approximately 15 to 30% of thyroid nodules evaluated by means of fine-needle aspiration are not clearly benign or malignant. Patients with cytologically indeterminate nodules are oftenExpand
  • 834
  • 61
  • PDF
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid
BACKGROUND Thyroid nodules are a common clinical problem, and differentiated thyroid cancer is becoming increasingly prevalent. Since the American Thyroid Association's (ATA's) guidelines for theExpand
  • 3,924
  • 35
  • PDF
Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification.
CONTEXT Cell lines derived from human cancers provide critical tools to study disease mechanisms and develop novel therapies. Recent reports indicate that up to 36% of cell lines are cross-Expand
  • 502
  • 25
  • PDF
Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules.
CONTEXT Thyroid nodules are common in adults, but only a small fraction of them are malignant. Fine-needle aspiration (FNA) with cytological evaluation is the most reliable tool for cancer diagnosisExpand
  • 429
  • 25
  • PDF
A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer.
Recombinant human TSH has been developed to facilitate monitoring for thyroid carcinoma recurrence or persistence without the attendant morbidity of hypothyroidism seen after thyroid hormoneExpand
  • 548
  • 15
Central hypothyroidism associated with retinoid X receptor-selective ligands.
BACKGROUND The occurrence of symptomatic central hypothyroidism (characterized by low serum thyrotropin and thyroxine concentrations) in a patient with cutaneous T-cell lymphoma during therapy withExpand
  • 243
  • 10
Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry.
The ideal therapy for differentiated thyroid cancer is uncertain. Although thyroid hormone treatment is pivotal, the degree of thyrotropin (TSH) suppression that is required to prevent recurrencesExpand
  • 276
  • 9
Outcomes of patients with differentiated thyroid carcinoma following initial therapy.
This analysis was performed to determine the effect of initial therapy on the outcomes of thyroid cancer patients. The study setting was a prospectively followed multi-institutional registry.Expand
  • 516
  • 8
  • PDF